The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

NCT04435769 ·Status: COMPLETED

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

NCT04066764 ·Status: RECRUITING ·Phase: PHASE3

Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

NCT04852406 ·Status: RECRUITING ·Phase: NA

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

NCT01317927 ·Status: COMPLETED ·Phase: PHASE1

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

NCT01400646 ·Status: COMPLETED ·Phase: PHASE1

Gene-guided Warfarin for Anticoagulation Therapy

NCT04482842 ·Status: WITHDRAWN ·Phase: NA

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

NCT03292666 ·Status: COMPLETED

A Drug-Drug Interaction Study of Warfarin and PA21

NCT01477424 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Reversal

NCT01159210 ·Status: COMPLETED ·Phase: PHASE4

Apixaban in Thrombocytopenia

NCT06886516 ·Status: RECRUITING ·Phase: EARLY_PHASE1

THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)

NCT05033314 ·Status: TERMINATED ·Phase: PHASE3

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT00216866 ·Status: COMPLETED ·Phase: PHASE2

Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist

NCT01348074 ·Status: COMPLETED ·Phase: PHASE2

Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines

NCT03506815 ·Status: COMPLETED ·Phase: PHASE3

High-dose Periop Statins for Prevention of DVT

NCT00259662 ·Status: COMPLETED ·Phase: NA

Anticoagulation Length in Cancer Associated Thrombosis

NCT01817257 ·Status: TERMINATED ·Phase: PHASE2

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

NCT00806624 ·Status: COMPLETED ·Phase: PHASE2

Excessive Warfarin Anticoagulation - Causes and Consequences

NCT02761941 ·Status: UNKNOWN

The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

NCT03185845 ·Status: UNKNOWN ·Phase: NA

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

NCT06862726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism

NCT00423683 ·Status: TERMINATED ·Phase: PHASE3

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

NCT02646267 ·Status: UNKNOWN ·Phase: PHASE4

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

NCT02502396 ·Status: COMPLETED

Prophylactic Anticoagulation for Catheter-related Thrombosis

NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4